Results 261 to 270 of about 54,156 (279)

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

European Heart Journal, 2016
Umberto Benedetto, Giuseppe Biondi-Zoccai, Thibault Lhermusier   +2 more
exaly  

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice

European Heart Journal, 2017
Marianne G Pouwer, J Wouter Jukema, Hans Mg Princen   +2 more
exaly  

Subtilisin‐like proteases in plant defence: the past, the present and beyond

Molecular Plant Pathology, 2018
Joana Figueiredo, Marta Sousa Silva, Andreia Figueiredo   +2 more
exaly  

Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)

Basic Research in Cardiology, 2015
, Klaus-Dieter Schlüter
exaly  

Degradation of ribonuclease by subtilisin

Biochimica et Biophysica Acta, 1955
S M, KALMAN, K, LINDERSTRØM-LANG, M, OTTESEN, F M, RICHARDS   +3 more
openaire   +2 more sources

Plant Subtilisins

2013
openaire   +1 more source

Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis

Journal of the American College of Cardiology, 2013
Ulrich Laufs
exaly  

Subtilisin Enzymes

1996
openaire   +1 more source

Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor

Journal of Biological Chemistry, 2015
Rocco Romagnuolo, Corey A Scipione, Michael B Boffa   +2 more
exaly  

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Signal Transduction and Targeted Therapy

exaly